Alto Neuroscience (ANRO) EPS (Basic) (2023 - 2026)

Alto Neuroscience (ANRO) reported EPS (Basic) of -$0.79 for Q1 2026, down 35.54% on a YoY basis from -$1.23 in Q1 2025, and down 43.93% sequentially from -$0.55 in Q4 2025.

Alto Neuroscience (ANRO) EPS (Basic) (2023 - 2026) Analysis & Trends

Alto Neuroscience (ANRO) has 4 years of EPS (Basic) data on file, last reported at -$0.79 in Q1 2026.

  • For the quarter ending Q1 2026, EPS (Basic) fell 35.54% year-over-year to -$0.79; the trailing twelve-month figure through Mar 2026 stood at -$69.15 (down 2828.76% YoY), and the FY2025 full-year result was -$3.88, up 1.79% from the prior year.
  • EPS (Basic) retreated to -$0.79 in Q1 2026, from -$0.55 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of -$0.55 in Q4 2025 to a low of -$68.38 in Q3 2025.
  • A 4-year average of -$7.44 and a median of -$0.79 in 2026 frame the typical range for EPS (Basic).
  • Across the five-year window, EPS (Basic) surged 78.91% in 2024 and slumped 10915.86% in 2025, its largest moves.
  • Tracing ANRO's EPS (Basic) over 4 years: stood at -$2.93 in 2023, then surged by 78.91% to -$0.62 in 2024, then grew by 10.67% to -$0.55 in 2025, then plunged by 43.93% to -$0.79 in 2026.
  • Business Quant data shows ANRO's EPS (Basic) at -$0.79 in Q1 2026, -$0.55 in Q4 2025, and -$68.38 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 0.00
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 0.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 0.16
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 4.06
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 6.99
7 Belite Bio 61.40 Bn 61.40 Bn - 0.00
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 5.90
9 Revolution Medicines 37.37 Bn 37.37 Bn - -2.29
10 Alto Neuroscience 869.36 Mn 869.36 Mn - -0.79

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.79
Dec 31, 2025 -0.55
Sep 30, 2025 -68.38
Jun 30, 2025 -14.00
Mar 31, 2025 -0.59
Dec 31, 2024 -0.62
Sep 30, 2024 -0.62
Jun 30, 2024 -0.60
Mar 31, 2024 -0.75
Dec 31, 2023 -2.93
Sep 30, 2023 -2.51
Jun 30, 2023 -2.38
Mar 31, 2023 -1.98